Given the intricate relationship between mTOR and the AKT pathway and their established crosstalk in various cancer types,49, 50 we were particularly interested in examining the effect of NSP‐B on mTOR activity in T‐ALL cells. The gene discussed is AKT1; the disease is acute lymphoblastic leukemia.